Yaning Yang

1.3k total citations
45 papers, 911 citations indexed

About

Yaning Yang is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Yaning Yang has authored 45 papers receiving a total of 911 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 29 papers in Pulmonary and Respiratory Medicine and 13 papers in Molecular Biology. Recurrent topics in Yaning Yang's work include Lung Cancer Treatments and Mutations (26 papers), Lung Cancer Research Studies (16 papers) and Colorectal Cancer Treatments and Studies (8 papers). Yaning Yang is often cited by papers focused on Lung Cancer Treatments and Mutations (26 papers), Lung Cancer Research Studies (16 papers) and Colorectal Cancer Treatments and Studies (8 papers). Yaning Yang collaborates with scholars based in China, United States and United Kingdom. Yaning Yang's co-authors include Yuanqiang Zhang, Yan Wang, Haiyan Xu, Shuangzheng Jia, Peiwen Sun, Jinhua Leng, Taisheng Li, Wei Cao, Yuanjie Li and Guangjian Yang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Yaning Yang

43 papers receiving 897 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yaning Yang China 13 362 284 221 210 160 45 911
Kim Ørnvold United States 14 148 0.4× 98 0.3× 67 0.3× 170 0.8× 46 0.3× 37 737
Mariangela Rutigliani Italy 11 109 0.3× 69 0.2× 123 0.6× 73 0.3× 22 0.1× 31 479
Kimon Tzannis Greece 11 99 0.3× 145 0.5× 26 0.1× 179 0.9× 43 0.3× 40 471
Sadao Yoshida Japan 13 336 0.9× 256 0.9× 21 0.1× 196 0.9× 19 0.1× 29 796
Serena Wong United States 18 272 0.8× 127 0.4× 9 0.0× 168 0.8× 95 0.6× 47 786
Asma Beldi‐Ferchiou France 13 348 1.0× 123 0.4× 127 0.6× 144 0.7× 11 0.1× 21 813
Giuseppina Dognini Italy 13 399 1.1× 102 0.4× 67 0.3× 93 0.4× 62 0.4× 26 766
Moritz Binder United States 19 143 0.4× 90 0.3× 19 0.1× 325 1.5× 32 0.2× 76 909
Giuseppe Colucci Italy 12 179 0.5× 82 0.3× 33 0.1× 91 0.4× 25 0.2× 28 548
Haruo Miwa Japan 16 296 0.8× 191 0.7× 24 0.1× 545 2.6× 9 0.1× 79 1.1k

Countries citing papers authored by Yaning Yang

Since Specialization
Citations

This map shows the geographic impact of Yaning Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yaning Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yaning Yang more than expected).

Fields of papers citing papers by Yaning Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yaning Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yaning Yang. The network helps show where Yaning Yang may publish in the future.

Co-authorship network of co-authors of Yaning Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Yaning Yang. A scholar is included among the top collaborators of Yaning Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yaning Yang. Yaning Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Ding, Yan, Jing Wang, Yihan Chen, Yaning Yang, & Xiaowei Liu. (2025). Natural transformation of antibiotic resistance genes and the enhanced adaptability in bacterial biofilm under antibiotic and heavy metal stresses. Journal of Hazardous Materials. 490. 137740–137740. 5 indexed citations
3.
Liu, Xiaowei, Yaning Yang, Lulu Ma, et al.. (2024). Quorum sensing regulating the heterogeneous transformation of antibiotic resistance genes in microplastic biofilms. Journal of environmental chemical engineering. 12(5). 113698–113698. 10 indexed citations
5.
Yang, Yaning, et al.. (2024). Abstract 3263: VEGFA mediates traditional EGFR-TKI resistance in non-small cell lung cancer with EGFR exon 20 insertions. Cancer Research. 84(6_Supplement). 3263–3263. 1 indexed citations
6.
Yang, Yaning, Guangjian Yang, Weihua Li, et al.. (2023). Pyrotinib plus antiangiogenic agents for HER2‐altered advanced non‐small cell lung cancer: A retrospective real‐world study. Thoracic Cancer. 14(33). 3275–3281. 5 indexed citations
7.
Xu, Haiyan, Yaning Yang, Fei Xu, et al.. (2023). Influence of PD‐L1 expression on the efficacy of EGFR‐TKIs in EGFR‐mutant non‐small cell lung cancer. Thoracic Cancer. 14(24). 2327–2337. 8 indexed citations
9.
Liu, Chengming, Lu Yang, Haiyan Xu, et al.. (2022). Systematic analysis of IL-6 as a predictive biomarker and desensitizer of immunotherapy responses in patients with non-small cell lung cancer. BMC Medicine. 20(1). 187–187. 55 indexed citations
10.
11.
Yang, Yaning & Yan Wang. (2022). Targeting exon 20 insertion mutations in lung cancer. Current Opinion in Oncology. 35(1). 37–45. 4 indexed citations
12.
Yang, Guangjian, Yaning Yang, Jiaqi Hu, et al.. (2022). EGFR exon 20 insertion variants A763_Y764insFQEA and D770delinsGY confer favorable sensitivity to currently approved EGFR-specific tyrosine kinase inhibitors. Frontiers in Pharmacology. 13. 984503–984503. 5 indexed citations
13.
Yang, Guangjian, Haiyan Xu, Jiaqi Hu, et al.. (2022). Specific HER2 Exon 20 Gly776 Deletion-Insertions in Non-Small Cell Lung Cancer: Structural Analysis and Sensitivity to HER2-Targeted Tyrosine Kinase Inhibitors. Frontiers in Pharmacology. 13. 806737–806737. 4 indexed citations
14.
Yang, Guangjian, Chengming Liu, Jiaqi Hu, et al.. (2022). The Lifted Veil of Uncommon EGFR Mutation p.L747P in Non-Small Cell Lung Cancer: Molecular Feature and Targeting Sensitivity to Tyrosine Kinase Inhibitors. Frontiers in Oncology. 12. 843299–843299. 7 indexed citations
16.
Yang, Guangjian, Xuezhi Hao, Jiaqi Hu, et al.. (2021). Pyrotinib in HER2 heterogeneously mutated or amplified advanced non-small cell lung cancer patients: a retrospective real-world study (PEARL). SHILAP Revista de lepidopterología. 1(4). 139–146. 10 indexed citations
17.
Zhang, Jingyi, Yaning Yang, Ru Chen, et al.. (2021). Assessment of racial differences in the incidence of thrombocytopenia induced by trastuzumab emtansine: a systematic review and meta-analysis. Annals of Translational Medicine. 9(14). 1139–1139. 7 indexed citations
19.
Yang, Guangjian, Haiyan Xu, Lu Yang, et al.. (2020). Apatinib in combination with pemetrexed-platinum chemotherapy for chemo-naive non-squamous non-small cell lung cancer: a phase II clinical study. Lung Cancer. 147. 229–236. 8 indexed citations
20.
Ci, Yali, Kejian Shi, Yaning Yang, et al.. (2014). ROS inhibit autophagy by downregulating ULK1 mediated by the phosphorylation of p53 in selenite-treated NB4 cells. Cell Death and Disease. 5(11). e1542–e1542. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026